Cargando…

Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report

INTRODUCTION: Type 2 endoleaks (T2EL) occur after 10%–25% of endovascular abdominal aortic aneurysm repairs and increase the risk factor of endograft repair failure and rupture. Herein we report a case of endovascular treatment of T2EL where we performed a trans-limb embolization. PRESENTATION OF CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinoto, E., Ferlito, F., Urso, F., Evola, S., Bajardi, G., Pecoraro, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349994/
https://www.ncbi.nlm.nih.gov/pubmed/34343793
http://dx.doi.org/10.1016/j.ijscr.2021.106238
_version_ 1783735654963740672
author Dinoto, E.
Ferlito, F.
Urso, F.
Evola, S.
Bajardi, G.
Pecoraro, F.
author_facet Dinoto, E.
Ferlito, F.
Urso, F.
Evola, S.
Bajardi, G.
Pecoraro, F.
author_sort Dinoto, E.
collection PubMed
description INTRODUCTION: Type 2 endoleaks (T2EL) occur after 10%–25% of endovascular abdominal aortic aneurysm repairs and increase the risk factor of endograft repair failure and rupture. Herein we report a case of endovascular treatment of T2EL where we performed a trans-limb embolization. PRESENTATION OF CASE: A 63-years-old male previously treated for AAA with endovascular aortic aneurysms repair (EVAR), showed an angio-CT scan followup with a type 2 endoleak fed from inferior mesenteric artery (AMI) with growth of AAA greater of 1 cm than preoperative CT-scan and increase of chronic lumbar pain. Due to high risk of rupture was performed a trans-limb embolization with complete sealing. The 6 months CT-angiography showed complete type 2 endoleak exclusion without changes of AAA. DISCUSSION: The risk of aneurysm rupture in the presence of an isolated T2EL is exceptionally low. However, when a persistent T2EL is associated with a significant sac size increase, commonly considered as at least 5 mm over 6 months, should be treated. Detachable coils are repositionable, allowing an extremely precise deployment and subsequent embolization of different targets. CONCLUSION: In this experience trans-limb embolization was feasible and this tool should be taken in account especially when no other surgical options exists.
format Online
Article
Text
id pubmed-8349994
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83499942021-08-15 Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report Dinoto, E. Ferlito, F. Urso, F. Evola, S. Bajardi, G. Pecoraro, F. Int J Surg Case Rep Case Report INTRODUCTION: Type 2 endoleaks (T2EL) occur after 10%–25% of endovascular abdominal aortic aneurysm repairs and increase the risk factor of endograft repair failure and rupture. Herein we report a case of endovascular treatment of T2EL where we performed a trans-limb embolization. PRESENTATION OF CASE: A 63-years-old male previously treated for AAA with endovascular aortic aneurysms repair (EVAR), showed an angio-CT scan followup with a type 2 endoleak fed from inferior mesenteric artery (AMI) with growth of AAA greater of 1 cm than preoperative CT-scan and increase of chronic lumbar pain. Due to high risk of rupture was performed a trans-limb embolization with complete sealing. The 6 months CT-angiography showed complete type 2 endoleak exclusion without changes of AAA. DISCUSSION: The risk of aneurysm rupture in the presence of an isolated T2EL is exceptionally low. However, when a persistent T2EL is associated with a significant sac size increase, commonly considered as at least 5 mm over 6 months, should be treated. Detachable coils are repositionable, allowing an extremely precise deployment and subsequent embolization of different targets. CONCLUSION: In this experience trans-limb embolization was feasible and this tool should be taken in account especially when no other surgical options exists. Elsevier 2021-07-26 /pmc/articles/PMC8349994/ /pubmed/34343793 http://dx.doi.org/10.1016/j.ijscr.2021.106238 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Dinoto, E.
Ferlito, F.
Urso, F.
Evola, S.
Bajardi, G.
Pecoraro, F.
Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report
title Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report
title_full Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report
title_fullStr Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report
title_full_unstemmed Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report
title_short Trans-limb embolization for treatment of Type 2 endoleak post EVAR: Case report
title_sort trans-limb embolization for treatment of type 2 endoleak post evar: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349994/
https://www.ncbi.nlm.nih.gov/pubmed/34343793
http://dx.doi.org/10.1016/j.ijscr.2021.106238
work_keys_str_mv AT dinotoe translimbembolizationfortreatmentoftype2endoleakpostevarcasereport
AT ferlitof translimbembolizationfortreatmentoftype2endoleakpostevarcasereport
AT ursof translimbembolizationfortreatmentoftype2endoleakpostevarcasereport
AT evolas translimbembolizationfortreatmentoftype2endoleakpostevarcasereport
AT bajardig translimbembolizationfortreatmentoftype2endoleakpostevarcasereport
AT pecorarof translimbembolizationfortreatmentoftype2endoleakpostevarcasereport